Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)

Keith W. Muir; Michael McCormick; Tracey Baird; Myzoon Ali

Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)

Keith W. Muir, Michael McCormick, Tracey Baird, Myzoon Ali

Research output: Contribution to journal › Article › peer-review

Abstract

Post-stroke hyperglycaemia (PSH) is associated with higher mortality and dependence, but further data on predictors of PSH and its evolution over time are required. We examined the prevalence, predictors, and prognosis of acute PSH using data from well-characterised clinical trials in the VISTA database. Methods: Data were extracted for individual participants enrolled ¿1 blood glucose readings documented. PSH was defined as glucose >7.0 mmol/l. Outcome measures were: (1) prevalence of PSH; (2) predictors of PSH by binary logistic regression; (3) mortality, and (4) favourable functional outcome [modified Rankin Scale (mRS) score

Original language	English
Pages (from-to)	17-27
Number of pages	11
Journal	Cerebrovascular Diseases
Volume	1
Issue number	1
Publication status	Published - 1 Jan 2011

Keywords

post-stroke hyperglycaemia
clinical trials
VISTA

Documents and Links

http://content.karger.com/produktedb/produkte.asp?doi=324319

Cite this

@article{1361575b89f043238ab83f6e7d3c1b9b,

title = "Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)",

abstract = "Post-stroke hyperglycaemia (PSH) is associated with higher mortality and dependence, but further data on predictors of PSH and its evolution over time are required. We examined the prevalence, predictors, and prognosis of acute PSH using data from well-characterised clinical trials in the VISTA database. Methods: Data were extracted for individual participants enrolled ¿1 blood glucose readings documented. PSH was defined as glucose >7.0 mmol/l. Outcome measures were: (1) prevalence of PSH; (2) predictors of PSH by binary logistic regression; (3) mortality, and (4) favourable functional outcome [modified Rankin Scale (mRS) score ",

keywords = "post-stroke hyperglycaemia, clinical trials, VISTA",

author = "Muir, {Keith W.} and Michael McCormick and Tracey Baird and Myzoon Ali",

note = "<p>Originally published in: Cerebrovascular Diseases (2011), 1(1), pp.17-27.</p>",

year = "2011",

month = jan,

day = "1",

language = "English",

volume = "1",

pages = "17--27",

journal = "Cerebrovascular Diseases",

issn = "1015-9770",

publisher = "S. Karger AG",

number = "1",

}

Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA). / Muir, Keith W.; McCormick, Michael; Baird, Tracey et al.

In: Cerebrovascular Diseases, Vol. 1, No. 1, 01.01.2011, p. 17-27.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)

AU - Muir, Keith W.

AU - McCormick, Michael

AU - Baird, Tracey

AU - Ali, Myzoon

N1 - <p>Originally published in: Cerebrovascular Diseases (2011), 1(1), pp.17-27.</p>

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Post-stroke hyperglycaemia (PSH) is associated with higher mortality and dependence, but further data on predictors of PSH and its evolution over time are required. We examined the prevalence, predictors, and prognosis of acute PSH using data from well-characterised clinical trials in the VISTA database. Methods: Data were extracted for individual participants enrolled ¿1 blood glucose readings documented. PSH was defined as glucose >7.0 mmol/l. Outcome measures were: (1) prevalence of PSH; (2) predictors of PSH by binary logistic regression; (3) mortality, and (4) favourable functional outcome [modified Rankin Scale (mRS) score

AB - Post-stroke hyperglycaemia (PSH) is associated with higher mortality and dependence, but further data on predictors of PSH and its evolution over time are required. We examined the prevalence, predictors, and prognosis of acute PSH using data from well-characterised clinical trials in the VISTA database. Methods: Data were extracted for individual participants enrolled ¿1 blood glucose readings documented. PSH was defined as glucose >7.0 mmol/l. Outcome measures were: (1) prevalence of PSH; (2) predictors of PSH by binary logistic regression; (3) mortality, and (4) favourable functional outcome [modified Rankin Scale (mRS) score

KW - post-stroke hyperglycaemia

KW - clinical trials

KW - VISTA

M3 - Article

VL - 1

SP - 17

EP - 27

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 1

ER -

Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)

Abstract

Keywords

Documents and Links

Fingerprint

Cite this